Dynacirc CR and Sumatriptan and naproxen
Determining the interaction of Dynacirc CR and Sumatriptan and naproxen and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Before using naproxen, tell your doctor if you also use isradipine. The combination may cause your blood pressure to increase. You may need a dose adjustment or your blood pressure checked more often. Also, if you are already taking the combination and stop taking naproxen, your blood pressure may decrease. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Limited data indicate that some cyclooxygenase inhibitors may attenuate the antihypertensive effects of some calcium channel blockers. The mechanism appears to be related to an alteration of vascular tone, which is dependent on prostacyclins and other vasodilatory prostanoids. When a nonsteroidal anti-inflammatory drug (NSAID) is added to the regimen of a patient who is already taking a calcium channel blocker, increased blood pressure may result. Also, the clinician should be aware that the risk of hypotension is increased when NSAIDs are withdrawn from the regimen.
MANAGEMENT: Monitoring for altered blood pressure control is recommended.
- Cremer KF, Pieper JA, Joyal M, Mehta J "Effects of diltiazem, dipyridamole, and their combination on hemostasis." Clin Pharmacol Ther 36 (1984): 641-4
- "Product Information. Arthrotec (diclofenac-misoprostol)." Searle, Skokie, IL.
- Deleeuw PW "Nonsteroidal anti-inflammatory drugs and hypertension: the risks in perspective." Drugs 51 (1996): 179-87
- "Product Information. Duract (bromfenac)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
- Zanchetti A, Hansson L, Leonetti G, et al. "Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy." J Hypertens 20 (2002): 1015-1022
- Houston MC, Weir M, Gray J, et al "The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil." Arch Intern Med 155 (1995): 1049-54
- Altman R, Scazziota A, Dujovne C "Diltiazem potentiates the inhibitory effect of aspirin on platelet aggregation." Clin Pharmacol Ther 44 (1988): 320-5
- Minuz P, Pancera P, Ribul M, et al "Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition." Br J Clin Pharmacol 39 (1995): 45-50
- Ring ME, Corrigan JJ, Fenster PE "Effects of oral diltiazem on platelet function: alone and in combination with "low dose" aspirin." Thromb Res 44 (1986): 391-400
Generic Name: isradipine
Brand name: Dynacirc, Dynacirc CR
Synonyms: Dynacirc CR (Oral), DynaCirc CR
Generic Name: naproxen / sumatriptan
Brand name: Treximet
Synonyms: Sumatriptan and Naproxen
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dynacirc CR-Sumatriptan injection
- Dynacirc CR-Sumatriptan Nasal Powder
- Dynacirc CR-Sumatriptan Nasal Spray
- Dynacirc CR-Sumatriptan Nasal, Oral, Subcutaneous
- Dynacirc CR-Sumatriptan oral/nasal
- Dynacirc CR-Sumatriptan Subcutaneous
- Sumatriptan and naproxen-Dynapen
- Sumatriptan and naproxen-Dyphylline
- Sumatriptan and naproxen-Dyphylline and guaifenesin
- Sumatriptan and naproxen-Dyphylline and Guaifenesin Liquid
- Sumatriptan and naproxen-Dyphylline and Guaifenesin Tablets
- Sumatriptan and naproxen-Dyphylline Oral, Intramuscular